bioRxivNeurosciencePreprint
TRIM32-UBQLN2-p62 axis promotes TDP-43 inclusion formation and amyloid aggregation through shuttle condensates
Ziyan He, Jiechao ZhouiD, Rongzhen ZhangiD, Fei Meng, David W. NaueniD, Juan Carlos TroncosoiD, Paul F. WorleyiD, Wenchi ZhangiD
Abstract
Aberrant protein aggregation is a hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), which share overlapping genetic and pathological features. Similar aggregates are increasingly recognized in Alzheimers disease (AD) and limbic-predominant age-related TDP-43 encephalopathy (LATE). However, it remains unclear whether a shared molecular pathway drives this pathological aggregation. Here, we report that the E3 ubiquitin ligase TRIM32, together with the shuttle factor UBQLN2 and the autophagy adaptor p62/SQSTM1, form condensates that depend on E3 ligase activity and a network of intermolecular interactions. These condensates act as scaffolds that capture UBQLN2 client proteins, including TDP-43 and ANXA11, and modulate their mobility. A unique hydrophobic loop within TRIM32s substrate-binding domain mimics low-complexity motifs in ANXA11 and TDP-43, enabling selective retention via competitive binding mediated by UBQLN2 STI1 domain. Moreover, TRIM32 condensates promote amyloid aggregation of TDP-43, an effect that is exacerbated by pathogenic UBQLN2 mutation. In brains from individuals with diverse neurodegenerative diseases, TRIM32 co-localizes with pathological phospho-TDP-43 (pTDP-43) inclusions, supporting a model in which TRIM32-driven condensates function as selective proteostasis sorting compartments that broadly contribute to TDP-43 proteinopathy.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: protein structure prediction
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
Laura R. Nementzik, Kyrah M. Thumbadoo, … Emma L. Scotter·bioRxiv·Feb 10, 2023
- ARPP21 defines a TDP-43-independent aggregation pathway in amyotrophic lateral sclerosis
Danae Campos‐Melo, Allison Ann Dilliott, … Cristian A. Droppelmann·bioRxiv·Sep 14, 2026
- TDP-43 oligomers detected as initial intermediate species during aggregate formation
R. L. French, A. N. Reeb, … Y. M. Ayala·bioRxiv·Dec 17, 2018
- Ubiquitin Proteasome System Components, RAD23A and USP13, Modulate TDP-43 Solubility and Neuronal Toxicity
Casey Dalton, Jelena Mojsilovic‐Petrovic, … Robert Gordon Kalb·Journal of NeurosciencePeer-reviewed·Dec 10, 2025
- Prion-like C-terminal domain of TDP-43 and α-Synuclein interact synergistically to generate neurotoxic hybrid fibrils
S. Dhakal, C. E. Wyant, … V. Rangachari·bioRxiv·Dec 12, 2020
- Deciphering the Amyloid Foldome of TDP-43
M. Mompean, E. Buratti, D. Laurents·bioRxiv·Aug 4, 2019